Journal
/
/
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid

3,160 Views

07:24 min

May 25, 2022

DOI:

07:24 min
May 25, 2022

20 Views
, , , , , ,

Summary

Automatically generated

Here we provide a detailed procedure for production, purification, and quantification of high-titer recombinant Newcastle disease virus. This protocol consistently yields > 6 × 109 plaque-forming units/mL, providing virus quantities appropriate for in vivo animal studies. Additional quality control assays to ensure safety in vivo are described.

Read Article